Tuesday, 31 May 2011
13.30 – 17.00
Impact of genetics in clinical practice
Chairpersons:
S. Tabrizi (London, UK)
A. Durr (Paris, FR)
A. Durr (Paris, FR)
Ethical issues
Peripheral neuropathy
Dementia
Ataxias/spastic paraplegia
13.30 – 17.00
Peripheral neuropathy, ALS and mimics
Chairpersons:
M. de Carvalho (Lisbon, PT)
O. Hardiman (Dublin, IE)
O. Hardiman (Dublin, IE)
The typical features which can indicate early ALS
Motor neuropathies mimicking ALS-MND
The role of neurophysiological studies (EMG and TMS) in differential diagnosis
The impact of the early ALS diagnosis in clinical trials
13.30 – 17.00
Hyperkinetic movement disorders
Chairpersons:
F. Cardoso (Belo Horizone, BR)
G. Deuschl (Kiel, DE)
G. Deuschl (Kiel, DE)
Tremor disorder
Dystonia
Jerky and stiff people
Chorea
13.30 – 17.00
Management of the dizzy patient
Chairpersons:
A. Bronstein (London, UK)
M. Strupp (Munich, DE)
M. Strupp (Munich, DE)
Approach to the dizzy patient
Diagnostics for differential diagnosis
Medical treatment
Physical therapy
13.30 – 17.00
Advances in the diagnosis of seizures and epilepsy
Chairpersons:
P. Boon (Ghent, BE)
M. Carreno (Barcelona, ES)
M. Carreno (Barcelona, ES)
How can seizures be subclassified based on clinical grounds?
What is the current role of EEG in the diagnosis of epilepsy?
Does MEG have a role in the diagnosis of epilepsy?
Is there an optimum magnetic resonance imaging protocol for epilepsy?
13.30 – 17.00
Intensive care in neurology
Chairpersons:
W. Hacke (Heidelberg, DE)
U. Meyding-Lamade (Frankfurt, DE)
U. Meyding-Lamade (Frankfurt, DE)
Life threatening meningitis
Hypothermia in neurocritical care
Treatment options for intracerebral and intraventicular haermorrgage
Critical care of ischaemic stroke
13.30 – 17.00
Antimicrobial chemotherapy for neurologists
Chairpersons:
B. Pfausler (Innsbruck, AT)
D. van de Beek (Amsterdam, NL)
D. van de Beek (Amsterdam, NL)